[RPRX] QoQ Quarter Result on 30-Jun-2023 [#Q2]

Stock
[RPRX] Royalty Pharma plc
Announcement Date
08-Aug-2023
Financial Year
2023
Quarter
30-Jun-2023 [#Q2]
Profit Trend
QoQ- -33.20%
YoY- -25.25%
Quarter Report
RPRX's Result
RPRX's Financial Summary
View:
Show?
Quarter Result
31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 CAGR
Revenue 567,978 596,000 536,313 538,202 683,971 565,748 573,463 -0.63%
PBT -4,273 718,000 122,077 351,336 509,089 -610,030 220,414 -
Tax -9,051 223,000 49,963 123,711 168,334 139 2,582 -
NP 4,778 494,340 72,114 227,625 340,755 -610,169 217,832 -92.14%
Tax Rate - -31.06% -40.93% -35.21% -33.07% - -1.17% -
Total Cost 563,200 101,660 464,199 310,577 343,216 1,175,917 355,631 35.82%
Ratio Analysis
31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 CAGR
NP Margin 0.84 82.94 13.45 42.29 49.82 -107.85 37.99 -92.10%
Per Share
31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 CAGR
EPS 0.01 1.11 0.16 0.51 0.76 -1.38 0.36 -90.80%
EPS Diluted 0.01 1.11 0.16 0.50 0.76 -1.38 0.36 -90.80%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.